An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed.
St. Jude Children’s Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences (PNAS).
The compound, (+)-SJ733, was developed from a molecule identified in a previous St. Jude-led study that helped to jumpstart worldwide anti-malarial drug development efforts. Malaria is caused by a parasite spread through the bite of an infected mosquito. The disease remains a major health threat to more than half the world’s population, particularly children. The World Health Organization estimates that in Africa a child dies of malaria every minute.
In this study, researchers determined that (+)-SJ733 uses a novel mechanism to kill the parasite by recruiting the immune system to eliminate malaria-infected red blood cells. In a mouse model of malaria, a single dose of (+)-SJ733 killed 80 percent of malaria parasites within 24 hours. After 48 hours the parasite was undetectable.
Planning has begun for safety trials of the compound in healthy adults.
Laboratory evidence suggests that the compound’s speed and mode of action work together to slow and suppress development of drug-resistant parasites. Drug resistance has long undermined efforts to treat and block malaria transmission.
“Our goal is to develop an affordable, fast-acting combination therapy that cures malaria with a single dose,” said corresponding author R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics. “These results indicate that SJ733 and other compounds that act in a similar fashion are highly attractive additions to the global malaria eradication campaign, which would mean so much for the world’s children, who are central to the mission of St. Jude.”
Whole genome sequencing of the Plasmodium falciparum, the deadliest of the malaria parasites, revealed that (+)-SJ733 disrupted activity of the ATP4 protein in the parasites. The protein functions as a pump that the parasites depend on to maintain the proper sodium balance by removing excess sodium.
The sequencing effort was led by co-author Joseph DeRisi, Ph.D., a Howard Hughes Medical Institute investigator and chair of the University of California, San Francisco Department of Biochemistry and Biophysics. Investigators used the laboratory technique to determine the makeup of the DNA molecule in different strains of the malaria parasite.
Researchers showed that inhibiting ATP4 triggered a series of changes in malaria-infected red blood cells that marked them for destruction by the immune system. The infected cells changed shape and shrank in size. They also became more rigid and exhibited other alterations typical of aging red blood cells. The immune system responded using the same mechanism the body relies on to rid itself of aging red blood cells.
Another promising class of antimalarial compounds triggered the same changes in red blood cells infected with the malaria parasite, researchers reported. The drugs, called spiroindolones, also target the ATP4 protein. The drugs include NITD246, which is already in clinical trials for treatment of malaria. Those trials involve investigators at other institutions.
“The data suggest that compounds targeting ATP4 induce physical changes in the infected red blood cells that allow the immune system or erythrocyte quality control mechanisms to recognize and rapidly eliminate infected cells,” DeRisi said. “This rapid clearance response depends on the presence of both the parasite and the investigational drug. That is important because it leaves uninfected red blood cells, also known as erythrocytes, unharmed.”
Laboratory evidence also suggests that the mechanism will slow and suppress development of drug-resistant strains of the parasite, researchers said.
The Latest on: Malaria
[google_news title=”” keyword=”Malaria” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Malaria
- Neena Valecha—stepping up malaria elimination efforts in southeast Asiaon September 27, 2023 at 4:40 pm
Neena Valecha has lots to smile about as she reflects on her long career. Inspired by her older sister to go into medicine, Valecha has had a long journey battling malaria, initially in various roles ...
- Mainstay malaria drug may be beginning to fail in the Horn of Africaon September 27, 2023 at 2:01 pm
In eastern Africa, malaria parasites have developed resistance to artemisinins, the backbone of current treatment regimens, a development that could dramatically worsen malaria's impact if partner ...
- Adventurer Aldo Kane Being Treated for Malaria in Hospitalon September 27, 2023 at 4:02 am
Adventurer, author and former Royal Marine, Aldo Kane has shared how he's currently in hospital being treated for malaria. The 45-year-old revealed on Instagram how he's currently recovering from ...
- Malaria cases dip in Adaklu districton September 26, 2023 at 7:21 am
Malaria cases in the Adaklu district have reduced slightly to 3,717, representing 11.7 per cent of the 10 top Out-Patient Department cases from January to June 2023.During the same period in 2022, ...
- Malaria Cases Could Ebb in an Even Hotter World. But Other Diseases Will Get Worseon September 25, 2023 at 5:00 pm
In early July, on one of the hottest days ever recorded globally, Colin Carlson walked into a radio studio in Washington, D.C., to answer some questions about how a warming climate is ...
- Get Healthy: Though numbers are small. local transmission of malaria is increasing in U.S.on September 25, 2023 at 6:30 am
We thought we had defeated malaria,” says Dr. Emily Landon, executive medical director of Infection Prevention and Control at UChicago Medicine.
- Higher dose antimalarial may be needed to combat relapsing malariaon September 25, 2023 at 6:08 am
Analysis of data from more than 6,800 patients located across 16 countries has supported the need to increase the dose of the antimalarial drug, primaquine, in malaria endemic countries.
- Eliminate malaria once and for all or it will come back stronger, UN warnedon September 22, 2023 at 9:02 pm
World faces ‘malaria emergency’ from resistance to insecticides, waning efficacy of drugs, funding shortfalls and climate change African leaders have warned that the world is facing the ...
- Stopping Malaria from Killing Children is a Matter of Urgency | Opinionon September 21, 2023 at 6:32 am
Nothing focuses the mind like visiting a ward where 24 infants with severe malaria are fighting for their lives. There is nothing like witnessing the silent desperation of a mother. No conversation ...
- Malaria is on the ropes in Bangladesh. But the parasite is punching backon September 20, 2023 at 4:22 pm
What does it take to beat malaria? Thousands of moccasins walking down rural roads, overnight bus rides for lab tests ... and a highly effective drug. But the parasite isn't going along with the plan.
via Bing News